Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    October 2024
  1. KORULA J
    In adults with metabolic dysfunction, the MAF-5 score predicted risk for liver fibrosis (AUC range, 0.73 to 0.81).
    Ann Intern Med. 2024;177:JC119.
    PubMed     Abstract available


    September 2024
  2. YANG JD, Kamath PS
    Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/M24-0894.
    PubMed    


  3. KIM GA, Lim YS, Han S, Choi GH, et al
    Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/M24-0384.
    PubMed     Abstract available


    July 2024
  4. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed     Abstract available


    June 2024
  5. MIRONOVA M, Sherker AH
    In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
    Ann Intern Med. 2024;177:JC63.
    PubMed     Abstract available


    April 2024
  6. LAKE JE, Kitch DW, Kantor A, Muthupillai R, et al
    The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354.
    PubMed    


  7. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
    Gastroenterology/Hepatology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
    PubMed     Abstract available


    June 2023
  8. LEE BP, Dodge JL, Mack WJ, Leventhal AM, et al
    National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018.
    Ann Intern Med. 2023;176:879-882.
    PubMed    


    February 2023
  9. MUKHERJEE S
    In nonalcoholic fatty liver disease, a diet of freshwater fish vs. freshwater fish plus red meat reduced liver fat.
    Ann Intern Med. 2023;176:JC20.
    PubMed     Abstract available


    December 2022

  10. Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/P22-0022.
    PubMed    


  11. HANSEN CD, Gram-Kampmann EM, Hansen JK, Hugger MB, et al
    Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/M22-1787.
    PubMed     Abstract available


    July 2022
  12. CEPEDA JA, Thomas DL, Astemborski J, Rudolph JE, et al
    Impact of Hepatitis C Treatment Uptake on Cirrhosis and Mortality in Persons Who Inject Drugs : A Longitudinal, Community-Based Cohort Study.
    Ann Intern Med. 2022 Jul 12. doi: 10.7326/M21-3846.
    PubMed     Abstract available


  13. KORETZ RL
    Aspirin use is associated with reduced risk for hepatocellular carcinoma.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0049.
    PubMed     Abstract available


  14. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Portal Vein Thrombosis: What Could Be the Cause?
    Ann Intern Med. 2022;175:CG1.
    PubMed    


    November 2021
  15. SEEBERG KA, Borgeraas H, Hofso D, Smastuen MC, et al
    Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/M21-1962.
    PubMed     Abstract available



  16. Summary for Patients: Do Gastric Bypass and Sleeve Gastrectomy Help Reduce Liver Fat Content and Scarring in Patients With Type 2 Diabetes?
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/P21-0012.
    PubMed    


    September 2021
  17. TRAN AN, Lim JK
    Care of the Patient With Abnormal Liver Test Results.
    Ann Intern Med. 2021;174:ITC129-ITC144.
    PubMed     Abstract available


    August 2021
  18. HERCUN J, Sherker AH
    In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    PubMed     Abstract available


    July 2021
  19. KORETZ RL
    In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available


  20. TAPPER EB, Bosch J
    Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.